DataMed Solutions is proud to announce that:

DataMed Solutions was  named a Top 5% Finalist for the ISPOR—The Professional Society for Health Economics and Outcomes Research 2022 Research Presentation Awards and thank our research colleagues at Bristol Myers Squibb  We will be presenting Patient Demographics, Clinical Characteristics, Treatment Patterns, and Survival Outcomes Associated with First-Line Treated Un-Resectable Advanced, Metastatic and Recurrent Esophageal Squamous Cell Carcinoma in the U.S.